Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Infectious Disease > Key Sub-Saharan African Infectious Disease Pharmaceutical Markets
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Key Sub-Saharan African Infectious Disease Pharmaceutical Markets

Published by Frost & Sullivan
Published February, 2008 Product code 62836
Content info 224 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Key Sub-Saharan African Infectious Disease Pharmaceutical Markets published by Frost & Sullivan in February, 2008. This report consists of 224 Pages and the price starts from US $ 6000.

Introduction

Abstract

Research was carried out on the infectious disease pharmaceutical market in key Sub-Saharan countries namely Kenya, Nigeria and Tanzania. A thorough PESTLE (Political, Economic, Social, Technology, Legal and Environmental) analysis was established for all the countries allowing for an accurate evaluation of external factors impacting the pharmaceutical industry. Market sizes were calculated for 2006 and forecasts determined for the period 2006 to 2012. In addition, market dynamics, such as challenges, drivers and restraints were also determined.

Table of Contents

1. Infectious Disease Pharmaceutical Markets in Key Sub-Saharan African Countries

  • 1. Executive Summary
  • 2. Research Scope and Methodology
  • 3. Research SummarySlide
  • 4. Country Analysis: Nigeria
  • 5. Country Analysis: Kenya
  • 6. Country Analysis: Tanzania
  • 7. Decision Support Databases
Back to Top